Naiké Vorbe experienced abdominal pain, constipation, and diarrhea. She learned at 31 that she had stage 3 colon cancer.

After developing treatments for rare tumors, SpringWorks Therapeutics is taking a buyout offer from Germany-based Merck KGaA.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

Natera has announced findings from a study evaluating its personalised tumour-informed molecular residual disease (MRD) test, ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an ...

Scientists are exploring bacteria's potential as cancer-fighting agents by genetically engineering them to target and destroy ...

Teddi Mellencamp continues to open up about her ongoing cancer journey. She explained that deciding to wear wigs and not wear ...

Neoadjuvant PD-1 blockade in early-stage mismatch repair–deficient solid rectal and non-rectal tumors can eliminate the need ...

In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor ...

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration ...

Dynamic remodeling of the endomembrane system is a core biological process essential for maintaining cellular ...

A study on fasting and the ketogenic diet uncovers a newfound weakness in pancreatic tumors, making them more susceptible to ...